Clinical Trial Update: Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of nelfinavir and temsirolimus in patients with advanced cancers, including renal cell carcinoma, has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Nelfinavir (Viracept) (nelfinavir)
• Temsirolimus (Torisel) (temsirolimus)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Renal Cell Cancer, Cancer | Phase 1 | Status: COMPLETED